Clinical and Laboratorial Features That May Differentiate 46,XY DSD due to Partial Androgen Insensitivity and 5α‐Reductase Type 2 Deficiency

NN Veiga-Junior, PAR Medaets… - International Journal …, 2012 - Wiley Online Library
The aim of this study was to search for clinical and laboratorial data in 46, XY patients with
ambiguous genitalia (AG) and normal testosterone (T) synthesis that could help to …

[PDF][PDF] Clinical and Laboratorial Features That May Differentiate 46, XY DSD due to Partial Androgen Insensitivity and 5α-Reductase Type 2 Deficiency

NN Veiga-Junior, PAR Medaets, CCT de Sousa Castro… - cyberleninka.org
The aim of this study was to search for clinical and laboratorial data in 46, XY patients with
ambiguous genitalia (AG) and normal testosterone (T) synthesis that could help to …

[HTML][HTML] Clinical and Laboratorial Features That May Differentiate 46, XY DSD due to Partial Androgen Insensitivity and 5α-Reductase Type 2 Deficiency

NN Veiga-Junior, PAR Medaets, RJ Petroli… - International Journal …, 2012 - ncbi.nlm.nih.gov
The aim of this study was to search for clinical and laboratorial data in 46, XY patients with
ambiguous genitalia (AG) and normal testosterone (T) synthesis that could help to …

Clinical and Laboratorial Features That May Differentiate 46, XY DSD due to Partial Androgen Insensitivity and 5α-Reductase Type 2 Deficiency

NN Veiga-Junior, PAR Medaets… - International …, 2012 - pubmed.ncbi.nlm.nih.gov
The aim of this study was to search for clinical and laboratorial data in 46, XY patients with
ambiguous genitalia (AG) and normal testosterone (T) synthesis that could help to …

[PDF][PDF] Clinical and Laboratorial Features That May Differentiate 46, XY DSD due to Partial Androgen Insensitivity and 5α-Reductase Type 2 Deficiency

NN Veiga-Junior, PAR Medaets, CCT de Sousa Castro… - scienceopen.com
The aim of this study was to search for clinical and laboratorial data in 46, XY patients with
ambiguous genitalia (AG) and normal testosterone (T) synthesis that could help to …

[PDF][PDF] Clinical and Laboratorial Features That May Differentiate 46, XY DSD due to Partial Androgen Insensitivity and 5α-Reductase Type 2 Deficiency

NN Veiga-Junior, PAR Medaets, CCT de Sousa Castro… - researchgate.net
The aim of this study was to search for clinical and laboratorial data in 46, XY patients with
ambiguous genitalia (AG) and normal testosterone (T) synthesis that could help to …

[PDF][PDF] Research Article Clinical and Laboratorial Features That May Differentiate 46, XY DSD due to Partial Androgen Insensitivity and 5α-Reductase Type 2 …

NN Veiga-Junior, PAR Medaets, CCT de Sousa Castro… - academia.edu
The aim of this study was to search for clinical and laboratorial data in 46, XY patients with
ambiguous genitalia (AG) and normal testosterone (T) synthesis that could help to …

Clinical and Laboratorial Features That May Differentiate 46, XY DSD due to Partial Androgen Insensitivity and 5α-Reductase Type 2 Deficiency.

NN Veiga-Junior… - International …, 2012 - search.ebscohost.com
The aim of this study was to search for clinical and laboratorial data in 46, XY patients with
ambiguous genitalia (AG) and normal testosterone (T) synthesis that could help to …

[PDF][PDF] Clinical and Laboratorial Features That May Differentiate 46, XY DSD due to Partial Androgen Insensitivity and 5α-Reductase Type 2 Deficiency

NN Veiga-Junior, PAR Medaets, CCT de Sousa Castro… - pdfs.semanticscholar.org
The aim of this study was to search for clinical and laboratorial data in 46, XY patients with
ambiguous genitalia (AG) and normal testosterone (T) synthesis that could help to …

Clinical and Laboratorial Features That May Differentiate 46, XY DSD due to Partial Androgen Insensitivity and 5α-Reductase Type 2 Deficiency.

NN Veiga-Junior, PA Medaets, RJ Petroli… - International Journal …, 2011 - europepmc.org
The aim of this study was to search for clinical and laboratorial data in 46, XY patients with
ambiguous genitalia (AG) and normal testosterone (T) synthesis that could help to …